Get the Stockscreener App
0.3605
11.96%
-0.0575
Protagenic Therapeutics Inc Stock (PTIX) Forecast
The Protagenic Therapeutics Inc (PTIX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.5435, representing a +328.16% increase from the current price of $0.3605. The highest analyst price target is $1.5632, and the lowest is $1.5238.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PTIX Price Target
Average 1.4325
(+297.36% Upside)
Is Protagenic Therapeutics Inc (PTIX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 57.83 | Neutral |
| STOCH(9,6) | 34.32 | Neutral |
| STOCHRSI(14) | 75.95 | Neutral |
| MACD(12,26) | 0.000482 | Buy |
| ADX(14) | 17.20 | Neutral |
| William %R | -58.79 | Neutral |
| CCI(14) | 115.76 | Buy |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.2717
Buy
|
0.2907
Buy
|
| MA20 |
0.2701
Buy
|
0.2829
Buy
|
| MA50 |
0.3006
Buy
|
0.3203
Buy
|
| MA100 |
0.4282
Sell
|
0.4081
Sell
|
| MA200 |
0.5611
Sell
|
0.5751
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, PTIX could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 4 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on PTIX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 57.83 indicates that PTIX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 34.32 indicates that PTIX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 75.95 indicates that PTIX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.2 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 115.76 indicates that PTIX is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term PTIX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Protagenic Therapeutics Inc financial reports and earnings history, Protagenic Therapeutics Inc (PTIX) stock could reach $3.2446 by 2030, $28.48 by 2040 and $42.04 by 2050. See the projected annual prices until 2050 of the Protagenic Therapeutics Inc stock below:
- Protagenic Therapeutics Inc (PTIX) is expected to reach an average price of $13.58 in 2035, with a high prediction of $13.31 and a low estimate of $13.58. This indicates an $3,668% rise from the last recorded price of $0.3605.
- Protagenic Therapeutics Inc (PTIX) stock is projected to chart a bullish course in 2040, with an average price target of $28.80, representing an $7,889% surge from its current level. The forecast ranges from a conservative $4.1966 to a sky-high $28.48.
- Our analysts predict Protagenic Therapeutics Inc (PTIX) to jump 5,362% by 2045, soaring from $20.39 to an average price of $19.69, potentially reaching $20.38. While $20.39 is the low estimate, the potential upside is significant.
- Protagenic Therapeutics Inc (PTIX) stock is expected to climb by 2050, reaching an average of $41.43, a $11,392% jump from its current level. However, a wide range of estimates exists, with high and low targets of $42.04 and $41.75, respectively, highlighting the market's uncertainty.
Protagenic Therapeutics Inc Stock (PTIX) Year by Year Forecast
Protagenic Therapeutics Inc Stock (PTIX) Price Forecast for 2025
Protagenic Therapeutics Inc Stock (PTIX) is expected to reach an average price of $1.5363 in 2025, with a high prediction of $1.7544 and a low estimate of $1.3181. This indicates an +326.15% rise from the last recorded price of $0.3605.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $1.8076 | $1.5238 | $1.5632 | +401.43% |
| June, 2025 | $1.6389 | $1.8989 | $1.6895 | +354.62% |
| July, 2025 | $1.32 | $1.3181 | $1.3687 | +266.14% |
| August, 2025 | $1.6832 | $1.4174 | $1.2872 | +366.91% |
| September, 2025 | $1.4868 | $1.5186 | $1.337 | +312.44% |
| October, 2025 | $1.4955 | $1.5539 | $1.4063 | +314.84% |
| November, 2025 | $1.8844 | $1.5551 | $1.5748 | +422.70% |
| December, 2025 | $1.1042 | $1.6238 | $1.7544 | +206.30% |
Protagenic Therapeutics Inc Stock (PTIX) Price Forecast for 2026
The predicted value for Protagenic Therapeutics Inc (PTIX) in 2026 is set at an average of $0.92. Estimates vary from a peak of $1.4619 to a trough of $0.378, indicating an +155.19% surge from the present price of $0.3605.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.1831 | $1.1831 | $1.0063 | +228.17% |
| February, 2026 | $1.4611 | $1.2329 | $1.2859 | +305.30% |
| March, 2026 | $1.3316 | $1.5116 | $1.4619 | +269.36% |
| April, 2026 | $0.9509 | $1.1106 | $1.0712 | +163.78% |
| May, 2026 | $0.7999 | $0.79 | $0.7199 | +121.87% |
| June, 2026 | $0.681 | $0.7391 | $0.7595 | +88.91% |
| July, 2026 | $0.3282 | $0.4882 | $0.5587 | -8.97% |
| August, 2026 | $0.5224 | $0.378 | $0.4476 | +44.91% |
| September, 2026 | $0.5065 | $0.497 | $0.4672 | +40.49% |
| October, 2026 | $1.2867 | $0.4261 | $0.9657 | +256.93% |
| November, 2026 | $1.1999 | $1.2455 | $1.2094 | +232.83% |
| December, 2026 | $1.089 | $1.1003 | $1.1272 | +202.09% |
Protagenic Therapeutics Inc Stock (PTIX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Protagenic Therapeutics Inc (PTIX) is $2.5733, with a high forecast of $5.1102 and a low forecast of $0.0364. This indicates an +613.81% increase from the last price of $0.3605.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.7433 | $0.9333 | $0.9483 | +106.18% |
| February, 2027 | $0.7224 | $0.7322 | $0.6879 | +100.39% |
| March, 2027 | $0.5751 | $0.5816 | $0.6023 | +59.52% |
| April, 2027 | $0.1908 | $0.3308 | $0.3614 | -47.07% |
| May, 2027 | $0.2199 | $0.0797 | $0.5896 | -38.99% |
| June, 2027 | $4.72 | $0.0364 | $4.4036 | +1,209% |
| July, 2027 | $3.1585 | $3.8185 | $3.3796 | +776.14% |
| August, 2027 | $4.077 | $4.0581 | $3.357 | +1,031% |
| September, 2027 | $3.7351 | $3.8559 | $3.8966 | +936.09% |
| October, 2027 | $3.9336 | $3.3344 | $3.4136 | +991.15% |
| November, 2027 | $4.2921 | $4.2332 | $3.5721 | +1,091% |
| December, 2027 | $6.1902 | $4.6717 | $5.1102 | +1,617% |
Protagenic Therapeutics Inc Stock (PTIX) Price Forecast for 2028
In 2028, Protagenic Therapeutics Inc (PTIX) is projected to reach an average price of $5.7889, with a high projection of $6.3272 and a low estimate of $5.2506. This indicates an +1,506% rise from the last price of $0.3605.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.6287 | $5.8491 | $5.6295 | +1,461% |
| February, 2028 | $6.5472 | $6.1283 | $6.2636 | +1,716% |
| March, 2028 | $6.2653 | $6.4457 | $6.3272 | +1,638% |
| April, 2028 | $6.1718 | $6.2426 | $6.1726 | +1,612% |
| May, 2028 | $6.0999 | $6.1691 | $6.1631 | +1,592% |
| June, 2028 | $5.6604 | $5.974 | $5.6816 | +1,470% |
| July, 2028 | $6.1789 | $6.04 | $6.0189 | +1,614% |
| August, 2028 | $5.653 | $6.0214 | $5.9522 | +1,468% |
| September, 2028 | $5.3847 | $5.4363 | $5.1555 | +1,394% |
| October, 2028 | $5.394 | $5.5399 | $5.2748 | +1,396% |
| November, 2028 | $5.1121 | $5.3701 | $5.2225 | +1,318% |
| December, 2028 | $5.2066 | $5.2506 | $5.0518 | +1,344% |
Protagenic Therapeutics Inc Stock (PTIX) Price Forecast for 2029
The 2029 price forecast for Protagenic Therapeutics Inc Stock (PTIX) is $3.9405 on average, with a high prediction of $5.2687 and a low estimate of $2.6122. This represents an +993.06% increase from the previous price of $0.3605.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.4287 | $5.1903 | $5.2687 | +1,406% |
| February, 2029 | $4.4272 | $4.6672 | $5.1284 | +1,128% |
| March, 2029 | $4.4425 | $4.4861 | $4.3436 | +1,132% |
| April, 2029 | $4.7842 | $4.6446 | $4.4682 | +1,227% |
| May, 2029 | $4.2823 | $4.3623 | $4.5839 | +1,088% |
| June, 2029 | $3.5808 | $3.8408 | $3.9848 | +893.30% |
| July, 2029 | $3.5798 | $3.6101 | $3.5196 | +893.02% |
| August, 2029 | $3.1675 | $3.2575 | $3.489 | +778.63% |
| September, 2029 | $2.8247 | $2.8659 | $3.0172 | +683.56% |
| October, 2029 | $2.7741 | $2.8341 | $2.8752 | +669.50% |
| November, 2029 | $2.6076 | $2.8126 | $2.7218 | +623.32% |
| December, 2029 | $3.2911 | $2.6122 | $3.2674 | +812.91% |
Protagenic Therapeutics Inc Stock (PTIX) Price Forecast for 2030
Protagenic Therapeutics Inc Stock (PTIX) is expected to reach an average price of $5.6611 in 2030, with a high forecast of $10.42 and a low forecast of $0.8986. This signifies an +1,470% surge from the last price of $0.3605.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.0393 | $3.0892 | $3.2446 | +743.07% |
| February, 2030 | $2.8271 | $2.9543 | $2.9988 | +684.21% |
| March, 2030 | $2.4562 | $2.6665 | $2.5869 | +581.32% |
| April, 2030 | $2.2147 | $2.3447 | $2.3608 | +514.33% |
| May, 2030 | $1.8128 | $1.9828 | $2.1043 | +402.85% |
| June, 2030 | $1.0713 | $1.4213 | $1.7124 | +197.16% |
| July, 2030 | $0.9344 | $1.0001 | $0.8198 | +159.19% |
| August, 2030 | $10.33 | $0.8986 | $10.42 | +2,765% |
| September, 2030 | $9.6072 | $9.7177 | $9.3189 | +2,565% |
| October, 2030 | $9.6744 | $9.9566 | $9.6449 | +2,584% |
| November, 2030 | $8.5521 | $9.3769 | $9.0532 | +2,272% |
| December, 2030 | $8.9098 | $8.9015 | $8.9204 | +2,372% |
2.65%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):